Breaking News on Supplements & Nutrition - EuropeUS edition

Report abuse about a comment

Resveratrol 2012

I, along with about 80 of the most important scientists and physicians in the US, Europe, Middle East, and Asia just participated in the Resveratrol 2012 scientific conference in the UK. The evidence for resveratrol's ability to prevent, and treat the diseases of our modern lifestyle and obesity were impressive to say the least. When I was interviewed 6 years ago I stated that Transmax resveratrol would be ultimately considered more important to human health than penicillin. At the conference, after my presentation, I amended this statement. I now believe that Transmax resveratrol will be more important to all antibiotics within 20 years. Its potential to prevent diabetes, cancers, cardio-vascular disease, and inflammatory conditions is unique amongst both natural compounds and pharmaceuticals.

Posted by James Betz
23 December 2012 | 21h21

Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.

Your name *
Your email *

We will not publish your email on the site

Reason *

Back to: DMAA, resveratrol, gut health, and omega-3’s: A year of science in the nutra sector

Spotlight

Flavonols may slash risk of vascular disease for women

Flavonols may slash risk of vascular disease for women

Increased intake of flavonols from tea and other sources may boost heart health for older women, with...

Yakult ordered to pull Olympics-themed advert in UK over health claims breach

Yakult ordered to pull Olympics-themed advert in UK over health claims breach

The UK Advertising Standards Authority (ASA) has slapped a ban on the broadcast of a Yakult TV...

Vitafoods Europe 2013 - Day Three
All the latest news and tweets live from the show

Vitafoods Europe 2013 - Day Three

The NutraIngredients team is reporting live from the key industry event all week. We will be sharing...

Cranberry veteran gathers forces against EU medical device products
Live from Vitafoods Europe 2013

Cranberry veteran gathers forces against EU medical device products

Gunter Haesaerts

President, Pharmatoka

EU health claims evolution: A submission rethink
Guest article

EU health claims evolution: A submission rethink

Now that the dust has settled on the health claims submission process we should all be very...

Researchers question the 'optimal' vitamin D dose for infants

Researchers question the 'optimal' vitamin D dose for infants

Dosage recommendations for vitamin D supplementation in infancy do not help to raise levels to those considered...